The CEO of YourChoice Therapeutics describes developing a birth control solution for men

blonca9
Jun 5, 2024
1 min read

Akash Bakshi explains how YourChoice is leveraging learnings about how men who are vitamin A deficient are infertile or subfertile to create a pharmacological, hormone free, birth control.

Recent Posts

See All

Cambridge, UK based Maxion Therapeutics raised a $72M series A in March to advance its KnotBody programs - which combine the benefits of knottins and antibodies and can target ion channels and GPCRs

ASGCT 2025: HuidaGene presented preclinical and early clinical data for its CRISPR Cas12 based program for DMD in a Presidential Symposium talk

ASGCT 2025: Dyno Therapeutics' CEO Eric Kelsic discusses the latest in capsids for CNS, ophthalmology, and neuromuscular conditions

The CEO of YourChoice Therapeutics describes developing a birth control solution for men

Recent Posts

Join the BiotechTV mailing list

Follow BiotechTV

Sponsors

Sponsor Spotlight